煌上煌(002695.SZ):浙江煌上煌擬新建年產8000噸醬滷食品加工建設項目
格隆匯2月28日丨煌上煌(002695.SZ)公佈,公司於2022年2月28日召開的第五屆董事會第十一次會議審議通過了《關於全資子公司新建年產8000噸醬滷食品加工建設項目暨使用超募資金對全資子公司增資的議案》,同意公司使用超募資金及自有資金對全資子公司浙江煌上煌食品有限公司(“浙江煌上煌”)增資20766萬元人民幣,其中使用超募資金增資5524.32萬元,自有資金增資15241.68萬元,增資資金4000萬元進入註冊資本,浙江煌上煌註冊資本由1000萬元增至5000萬元,其餘16766萬元進入資本公積,用於新建“年產8000噸醬滷食品加工建設項目”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.